LBRX
LB Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.57 / 10
Underperform
Assessment shows weak fundamentals at 2.6/10. Constructive elements: Inventory turnover ratio and Interest coverage ratio (EBIT / Interest expense) (%), balanced by issues in PB-ROE and Asset-MV. Investment case: defensive.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight26.59%
1M Return11.03%
Value-0.26
Score3/3
Weight26.59%
1M Return11.03%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.21%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.21%
1M Return-1.23%
PB-ROE
Value0.06
Score1/3
Weight21.58%
1M Return8.79%
Value0.06
Score1/3
Weight21.58%
1M Return8.79%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.19%
1M Return0.10%
Value92.79
Score2/3
Weight0.19%
1M Return0.10%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.82%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.82%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.71%
1M Return0.88%
Value78.62
Score3/3
Weight1.71%
1M Return0.88%
Profit-MV
Value0.47
Score2/3
Weight21.34%
1M Return8.99%
Value0.47
Score2/3
Weight21.34%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.30%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.30%
1M Return-1.25%
Asset-MV
Value-0.51
Score0/3
Weight14.42%
1M Return6.58%
Value-0.51
Score0/3
Weight14.42%
1M Return6.58%
Cash-MV
Value-0.07
Score2/3
Weight20.49%
1M Return8.80%
Value-0.07
Score2/3
Weight20.49%
1M Return8.80%
Revenue-MV
Value-0.26
Score3/3
Weight26.59%
1M Return11.03%
Value-0.26
Score3/3
Weight26.59%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.71%
1M Return0.88%
Value78.62
Score3/3
Weight1.71%
1M Return0.88%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.21%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.21%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight21.34%
1M Return8.99%
Value0.47
Score2/3
Weight21.34%
1M Return8.99%
PB-ROE
Value0.06
Score1/3
Weight21.58%
1M Return8.79%
Value0.06
Score1/3
Weight21.58%
1M Return8.79%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.30%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.30%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.19%
1M Return0.10%
Value92.79
Score2/3
Weight0.19%
1M Return0.10%
Asset-MV
Value-0.51
Score0/3
Weight14.42%
1M Return6.58%
Value-0.51
Score0/3
Weight14.42%
1M Return6.58%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.82%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.82%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight20.49%
1M Return8.80%
Value-0.07
Score2/3
Weight20.49%
1M Return8.80%
Is LBRX undervalued or overvalued?
- LBRX scores 2.57/10 on fundamentals and holds a Premium valuation at present. Backed by its -8.32% ROE, 0.00% net margin, -36.24 P/E ratio, 2.20 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.
